AI assistant
BOSTON SCIENTIFIC CORP — Director's Dealing 2024
May 13, 2024
29821_dirs_2024-05-13_a6b9d4ba-17d4-4ef7-9cea-6919d2ca1e3d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2024-05-09
Reporting Person: Morano Susan E (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-05-09 | Common Stock | A | 1450.0000 | $0.0000 | Acquired | 3532.0000 | Direct |
| 2024-05-09 | Common Stock | A | 421.0000 | $0.0000 | Acquired | 3953.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-05-09 | Deferred Stock Units | $ | A | 1450.0000 | Acquired | Common Stock (1450.0000) | Direct | |
| 2024-05-09 | Deferred Stock Units | $ | A | 421.0000 | Acquired | Common Stock (421.0000) | Direct |
Footnotes
F1: Annual equity award in the form of restricted stock vesting in full upon the next annual meeting of stockholders. Reflects a value of $107,500 (representing 50% of the amount of the non-employee director compensation program's annual equity award having a value of $215,000) divided by the closing price of common stock on the date of grant.
F2: Grant of restricted stock in lieu of 25% yearly cash compensation. Reflects a value of approximately $31,250 (representing 25% of the amount of the non-employee director compensation program's cash retainer having a value of $125,000) divided by the closing price of the common stock on the date of grant.
F3: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F4: Annual equity award in the form of deferred stock units vesting in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Director service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. Reflects a value of $107,500 (representing 50% of the non-employee director compensation program's annual equity award having a value of $215,000) divided by the closing price of common stock on the date of grant.
F5: Deferred stock units were granted in lieu of 25% yearly cash compensation and vest in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. Reflects a value of $31,250 (representing 25% of the amount of the non-employee director compensation program's cash retainer having a value of $125,000) divided by the closing price of the common stock on the date of grant.